• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Masimo wins $467m verdict in patent spat with Philips

Masimo wins $467m verdict in patent spat with Philips

October 2, 2014 By Alex Soule

Masimo wins $467m verdict in patent spat with Philips

Masimo (NSDQ:MASI) yesterday won a $467 million patent infringement verdict over Royal Philips (NYSE:PHG) in a long-standing battle over pulse oximetry technology.

Although Philips stipulated that it did infringe the patents, it argued that the infringement was moot because the patents are invalid. The jury disagreed, denying Philips’ claim that 2 Masimo patents are invalid and finding that Masimo did not infringe a 3rd Philips patent.

Masimo sued Philips in 2009 in the U.S. District Court for Delaware; Philips filed a counter-claim later that year. The companies are also litigating a 2nd infringement case brought by Masimo, which is also being heard in Delaware under Judge Leonard Stark.

After 13 years of denials, Philips suddenly admitted to the infringement just before a pretrial conference in August, Masimo lawyer Joseph Re of Knobbe Martens Olson & Bear told Law360.

"We’re so pleased that the jury saw just how valuable this technology has been to improve patient health care," Re said. "This type of case is exactly what the patent system was designed to accomplish: Protect real innovation."

Philips vowed to appeal the verdict.

"We are very disappointed in the verdict of the jury and surprised by the magnitude of the proposed award," CEO Frans van Houten said in prepared remarks. "Philips intends to pursue all avenues of appeal of this verdict at both the district and appellate courts in the U.S."

If sustained, the verdict would be the 3rd-largest returned by a jury this year, according to Bloomberg. 

The news pushed MASI shares up 13% in after-hours trading yesterday, to just over $24 apiece, their highest level since early August. The stock opened today at $24 per share but subsided to $22.46 per share as of about 10:20 a.m. Eastern, down 6.5%; PHG shares were trading at $30.73, down 0.9%.

Filed Under: Legal News, News Well, Patent Infringement, Patient Monitoring Tagged With: Masimo, Philips

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy